Startups
Navis Bio structures biomedical evidence for indication prioritization and target selection in pharmaceutical R&D.
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 22, 2025 | DayOne Accelerator reveals latest cohort | The DayOne Accelerator is a three-month hybrid program for high-potential, early-stage techbio and healthtech ventures working at the intersection with Pharma R&D. Following the program revamp this year, the program coordinators are no... |
| Feb 18, 2025 | A realm of AI applications at Microsoft AI Tech Accelerator | This year, Microsoft for startups Switzerland has significantly enhanced its program focusing on building a collaborative innovation ecosystem to reflect the momentum in AI innovation across Switzerland. The new AI Tech Accelerator Communi... |
Reviews 0
FAQ about Navis Bio
What has the press written about Navis Bio?
Parsers VC has collected 3 articles mentioning Navis Bio, among them “DayOne Accelerator reveals latest cohort” (Aug 22, 2025) and “A realm of AI applications at Microsoft AI Tech Accelerator” (Feb 18, 2025).
Is Navis Bio still active?
Yes, Navis Bio is active; its latest activity on Parsers VC dates from Dec 17, 2025.